Pradefovir

CAS : 625095-60-5

Ref. 3D-AAB09560

Informations sur le produit

• Nom: Pradefovir
• Marque: Biosynth
• Description: Pradefovir is a hydroxyl prodrug that is converted to its active form, Pradofloxacin, by esterases in the liver. Pradofloxacin has been shown to be effective against hiv and hepatitis C virus infections. This drug also has anti-inflammatory properties and inhibits the expression of toll-like receptor 4 (TLR4), which plays a role in HIV infection. Pradofloxacin has been approved for use as an oral prodrug for the treatment of hepatic steatosis. It is not known whether or not Pradofloxacin has any effect on TLR2 or TLR9 receptors.

Propriétés chimiques

• Masse moléculaire: 423.8 g/mol
• Formule: C₁₇H₁₉ClN₅O₄P
• Degré de pureté: Min. 95%